Partners
Coordinators
Workpackage leaders
Partners
Coordinators
Coordinator
Name
Organisation/Institution
Contact
Financial
Dr. Leila Risteli
Research and Innovation Services, University of Oulu, FIN
Scientific and technical
Dr. Cecilia Clemedson
Workpackage leaders
Workpackage
Participating partners
Workpackage leader
Contact
WP 1: Generation of a high quality in vivo (animal and human)database
P4, P24, P29, P36
Thomas Cole
WP 2: Generation of a high quality in vitro database
P8, P14, P15, P23
Dr. Richard Clothier
University of Nottingham, Nottingham, UK
WP 3: Iteritive amendment of the testing strategy
P4, P10, P17, P19, P26
Dr. Sandra Coecke
WP 4: New cell systems and new endpoints
P9, P11, P14, P21
Prof. José-Enrique O´Connor
WP 5: Role of adsorption, distribution and elimination
P5, P6, P13, P15, P27, P34, P35
Dr. Bas Blaauboer
WP 6 : Role of metabolism
P3, P7, P15, P23, P31
Dr. Maria José Gómez-Lechón
WP 7.1: Role target organ toxicity (brain)
P4, P5, P13, P16, P20, P37
Dr. Anna Forsby
WP 7.2: Role target organ toxicity (kidney)
P18, P25
Prof. Michael P.Ryan
WP 7.3: Role target organ toxicity (liver)
P3, P9, P12, P15, P18, P28, P31
Prof. José Castell
WP 8: Technical optimisation of the modified testing strategy
P1, P2, P3, P4, P5, P6 , P8, P9, P16, P25, P26, P32
Dr. Bas Blaauboer
WP 9: Prevalidation of the testing strategy
P2, P3, P4, P5, P6, P8, P9, P16, P25
Dr. Pilar Prieto
WP 10: Management, dissemination and exploitation of results
P1, P2, P3, P4, P5, P6, P8, P9, P16, P25, P33
Dr. Leila Risteli
Partners
No
Name
Organisation/ Institution
Contact
1
Dr. Leila Risteli
Research and Innovation Services, University of Oulu, FIN
3
Prof. José Castell
Dr. Maria Jose Gomez-LechonUniversity Hospital La Fe, Valencia, ES
4
Dr. Pilar Prieto
Dr. Thomas Cole
Dr. Sandra Coecke
Dr. Agnieszka KinsnerInstitute for Health and Consumer Protection, ECVAM, Joint Research Centre, I
5
Dr. Joan-Albert Vericat
Noscira, Madrid, ES
6
Dr. Bas Blaauboer
Institute of Risk Assessment Sciences, Utrecht University, NL
7
Dr. Christina Herder
Biovitrum, Stockholm, SE
8
Dr. Richard Clothier
University of Nottingham, Nottingham, UK
9
Prof. José-Enrique O´Connor
The University of Valencia, Department of Biochemistry and Molecular Biology, ES
10
Dr. Laurence Lafanechere
Centre de Griblage de Molécules Bio-actives, Grenoble, FR
11
Dr. Juan A Bueren
CIEMAT, Madrid, ES
12
Prof. Pedro Buc Calderon
Universite Catholoique de Louvain, B
13
Dr. Cristina Sunol
Dr Nuria CampilloConsejo Superior de Investigaciones Cientificas, ES
14
Dr. Hilde Millaire
Institute of Public Health, Lab. Biochemical Toxicology, B
15
Dr. Myriam Fabre
Advanced In Vitro Cell Technologies, S.L.,
C/ Baldiri i Reixac, Barcelona, ES16
Dr. Anna Forsby
Dr. Cecilia ClemedsonDept. of Neurochemistry, Stockholm University, SE
17
Dr. Hans Juergen Ahr
Bayer AG Elberfeld, D
18
Prof. Gabrielle Hawksworth
Department of Biomedical Sciences, Institute of Medical Sciences, University of Aberdeen, UK
19
Prof. Robert Rudowski
Department of Medical Informatics, Medical University of Warsaw, PL
20
Prof. Paul Honegger
Institute of Physiology, University of Lausanne, CH
21
Prof. Ron Kooijman
Department of Pharmacology, Free University of Brussels, B
23
Dr. Mónica Betanzos
FUNDACIÓN GAIKER, Zamudio, ES
24
Dr. Christina Rudén
Royal Institute of Technology, Stockholm, SE
25
Prof. Michael P. Ryan
Department of Pharmacology, University of College Dublin, IE
26
Prof. Michael Sjöström
Dept. of Chemistry, Chemometric group, Umeå University, SE
27
Dr. Laura Turco
Istituto Superiore di Sanità, Roma, I
28
Prof. Bruno Stieger
University Hospital, Div. Clinical Pharmacology & Toxicology, Zürich, CH
29
Dr. Inge Mangelsdorf
Fraunhofer, Institute of Toxicology and Experimental Medicine, Hannover, D
31
Prof. Jitka Ulrichová
Institute of Medical Chemistry and Biochemistry, Faculty of Medicin, Palacky University, Olomouc, CZ
33
Dr. Marcel Leist
STZ InPuT, Konstanz, D
34
Prof. Per Artursson
Deparment of Pharmacy, Uppsala University, Uppsala, SE
35
Prof. Roméo Cecchelli
University of Artois, Institut Pasteur de Lille, Lens, FR
36
Dr. Ada Kolman
Swedish Fund for Research without Animal Experiments, Stockholm, SE
37
Prof. Victor Rimbau
Department of Pharmacology and Therapeutical Chemistry, University of Barcelona, ES